TP53 and colonic neoplasm: Moreover, miR-338-3p confers resistance to 5-FU in p53 mutant colon cancer through mTOR downregulation-induced autophagy, indicating that targeting miR-338-3p is a promising strategy to overcome 5-FU resistance in p53 mutant colon cancer (199).